319 related articles for article (PubMed ID: 32615038)
1. Microfluidic Immunoassays for Sensitive and Simultaneous Detection of IgG/IgM/Antigen of SARS-CoV-2 within 15 min.
Lin Q; Wen D; Wu J; Liu L; Wu W; Fang X; Kong J
Anal Chem; 2020 Jul; 92(14):9454-9458. PubMed ID: 32615038
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG.
Gambino CM; Lo Sasso B; Colomba C; Giglio RV; Agnello L; Bivona G; Ciaccio M
Biochem Med (Zagreb); 2020 Oct; 30(3):030901. PubMed ID: 33071558
[TBL] [Abstract][Full Text] [Related]
3. Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays.
Qian C; Zhou M; Cheng F; Lin X; Gong Y; Xie X; Li P; Li Z; Zhang P; Liu Z; Hu F; Wang Y; Li Q; Zhu Y; Duan G; Xing Y; Song H; Xu W; Liu BF; Xia F
Clin Chem Lab Med; 2020 Aug; 58(9):1601-1607. PubMed ID: 32609640
[TBL] [Abstract][Full Text] [Related]
4. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
[TBL] [Abstract][Full Text] [Related]
5. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
[TBL] [Abstract][Full Text] [Related]
6. [The diagnostic value of rapid anti IgM and IgG detecting tests in the identification of patients with SARS CoV-2 virus infection].
Vásárhelyi B; Kristóf K; Ostorházi E; Szabó D; Prohászka Z; Merkely B
Orv Hetil; 2020 May; 161(20):807-812. PubMed ID: 32364358
[TBL] [Abstract][Full Text] [Related]
7. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation.
Jääskeläinen AJ; Kuivanen S; Kekäläinen E; Ahava MJ; Loginov R; Kallio-Kokko H; Vapalahti O; Jarva H; Kurkela S; Lappalainen M
J Clin Virol; 2020 Aug; 129():104512. PubMed ID: 32563180
[TBL] [Abstract][Full Text] [Related]
8. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study.
Pérez-García F; Pérez-Tanoira R; Romanyk J; Arroyo T; Gómez-Herruz P; Cuadros-González J
J Clin Virol; 2020 Aug; 129():104473. PubMed ID: 32504945
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.
Velay A; Gallais F; Benotmane I; Wendling MJ; Danion F; Collange O; De Sèze J; Schmidt-Mutter C; Schneider F; Bilbault P; Meziani F; Fafi-Kremer S
Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115181. PubMed ID: 32957073
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
[TBL] [Abstract][Full Text] [Related]
11. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
[TBL] [Abstract][Full Text] [Related]
12. Detection of serum IgM and IgG for COVID-19 diagnosis.
Zhong L; Chuan J; Gong B; Shuai P; Zhou Y; Zhang Y; Jiang Z; Zhang D; Liu X; Ma S; Huang Y; Lin H; Wang Q; Huang L; Jiang D; Hao F; Tang J; Zheng C; Yu H; Wang Z; Jiang Q; Zeng T; Luo M; Zeng F; Zeng F; Liu J; Tian J; Xu Y; Long T; Xu K; Yang X; Liu Y; Shi Y; Jiang L; Yang Z
Sci China Life Sci; 2020 May; 63(5):777-780. PubMed ID: 32270436
[No Abstract] [Full Text] [Related]
13. Comparative analysis of the main haematological indexes and RNA detection for the diagnosis of SARS-CoV-2 infection.
Xiang J; Chen Z; Zhou J; Tian D; Ran X; Zhang Z; Shi S; Xiao D; Zhou Y
BMC Infect Dis; 2020 Oct; 20(1):779. PubMed ID: 33081702
[TBL] [Abstract][Full Text] [Related]
14. Serological chemiluminescence immunoassay for the diagnosis of SARS-CoV-2 infection.
Lijia S; Lihong S; Huabin W; Xiaoping X; Xiaodong L; Yixuan Z; Pin H; Yina X; Xiaoyun S; Junqi W
J Clin Lab Anal; 2020 Oct; 34(10):e23466. PubMed ID: 32671890
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies.
Beavis KG; Matushek SM; Abeleda APF; Bethel C; Hunt C; Gillen S; Moran A; Tesic V
J Clin Virol; 2020 Aug; 129():104468. PubMed ID: 32485620
[TBL] [Abstract][Full Text] [Related]
16. Rapid Detection of COVID-19 by Serological Methods and the Evaluation of Diagnostic Efficacy of IgM and IgG.
Huang S; Lin C; Yan M; Li H; Liu T; Michael W; Xiang J; Shen C
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180423
[TBL] [Abstract][Full Text] [Related]
17. Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays.
Wolff F; Dahma H; Duterme C; Van den Wijngaert S; Vandenberg O; Cotton F; Montesinos I
Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115140. PubMed ID: 32829098
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19.
Imai K; Tabata S; Ikeda M; Noguchi S; Kitagawa Y; Matuoka M; Miyoshi K; Tarumoto N; Sakai J; Ito T; Maesaki S; Tamura K; Maeda T
J Clin Virol; 2020 Jul; 128():104393. PubMed ID: 32387968
[TBL] [Abstract][Full Text] [Related]
19. Utility of lateral flow tests in SARS-CoV-2 infection monitorization.
Candel FJ; Viñuela-Prieto JM; González Del Castillo J; Barreiro García P; Fragiel Saavedra M; Hernández Píriz A; Jiménez Virumbrales D; Canora Lebrato J; García de Casasola G; Gil Prieto R; San-Román Montero J; Ortega Anselmi J; Barba Martín R; Prados Roa F; Marco Martínez J; Zapatero Gaviria A
Rev Esp Quimioter; 2020 Aug; 33(4):258-266. PubMed ID: 32492991
[TBL] [Abstract][Full Text] [Related]
20. Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection.
Serrano MM; Rodríguez DN; Palop NT; Arenas RO; Córdoba MM; Mochón MDO; Cardona CG
J Clin Virol; 2020 Aug; 129():104529. PubMed ID: 32659710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
